Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

CHASE and Medacy will be attending Clinical Pharmacy Congress 2023

CHASE and Medacy will be in attendance at this year's Clinical Pharmacy Congress (CPC) on 12 - 13 May 2023 at the ExCeL Centre in London.

CHASE

- PMLiVE

Caroline Pond joins CHASE as NHS Partnership Working Director

CHASE is delighted to welcome Caroline Pond as NHS Partnership Working Director.

CHASE

- PMLiVE

GSK welcomes Canadian court ruling to dismiss Zantac litigation

The company and other drugmakers have been facing thousands of lawsuits claiming ranitidine caused cancer

- PMLiVE

Amgen and TScan Therapeutics partner to identify new Crohn’s disease targets

Inflammatory bowel disease affects nearly one in every 100 people in the US

- PMLiVE

VMLY&R and KDog join forces in project to train abandoned dogs to become medical detection dogs

Dogs Without Borders is a unique project that trains abandoned dogs to become medical detection dogs that can diagnose people living in remote communities

Real-World Impact of Continuing Medical Education on Physician Behavior in Prevention of Migraine

During the Alliance For Continuing Education in the Health Professions Industry Summit Medscape Education was awarded a Best in Class designation for its use of Real-World Outcomes to measure the impact of...

Medscape Education

New syndicated reports now available

Living with CD, PsO, IPF & PF-ILD 2023

Inizio

Hyper-personalisation – The immediate future of pharma is personalised.

What does hyper-personalisation in Pharma look like?

Mednet

Train your brain for success

In this episode of Impetus Digital‘s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Max Newlon, President of Brain Co. They discuss everything from...

Impetus Digital

- PMLiVE

Sobi to acquire CTI BioPharma for approximately $1.7bn

The deal marks a notable expansion to the Swedish drugmaker's rare haematology pipeline

- PMLiVE

Novavax announces positive phase 2 results for COVID-19/influenza vaccine candidates

A combination COVID-19/influenza vaccine is included in the mid-stage study

- PMLiVE

Sandoz and Just-Evotec Biologics announce multi-year biosimilar partnership

The Novartis unit will aim to expand its current pipeline of biosimilars to about 24 candidates

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links